Abstract: The present invention provides a phosphorus-containing compound characterized by being a compound represented by the following structure: the compound is a novel immune cell migration inhibitor. The compound has good hydrophilicity and can be developed into eye drops. The compound has a strong inhibitory ability to immune cell migration and can relieve the symptoms of most dry-eye patients.
Type:
Grant
Filed:
May 21, 2018
Date of Patent:
May 10, 2022
Assignee:
VivaVisionShanghaiLtd
Inventors:
Wang Shen, Yue Ding, Hao Jiang, Fu li Chen, Jiangfeng Wang, Xinglong Wu, Cunfei Li, Liguo Yang, Biao Hu, Qiyang Jiang, Zhixing An, Kuifeng Dang
Abstract: The present invention provides a phosphorus-containing compound characterized by being a compound represented by the following structure: the compound is a novel immune cell migration inhibitor. The compound has good hydrophilicity and can be developed into eye drops. The compound has a strong inhibitory ability to immune cell migration and can relieve the symptoms of most dry-eye patients.
Type:
Application
Filed:
May 21, 2018
Publication date:
April 30, 2020
Applicant:
VivaVisionShanghaiLtd
Inventors:
Wang SHEN, Yue DING, Hao JIANG, Fu li CHEN, Jiangfeng WANG, Xinglong WU, Cunfei LI, Liguo YANG, Biao HU, Qiyang JIANG, Zhixing AN, Kuifeng DANG